Zymeworks Inc.

IPO

Making a Meaningful Difference — Zymeworks

Public · Vancouver, Canada · Founded 2003 · $65.0M raised

Employees
201–500
Founded
2003
Business Model
B2B
Total Funding
$65.0M
Last Round
$61.5M Venture RoundJan 2015
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Zymeworks is a royalty-driven biotechnology company managing a portfolio of healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics. The company's healthcare asset aggregation strategy focuses on optimizing future cash flows from an emerging licensed product portfolio, including Ziihera (zanidatamab-hrii) and pasritamig, which are currently being investigated in over 15 clinical trials across a number of solid tumor indications.

Summary

Zymeworks Inc. is a Biotech company based in Vancouver, Canada, founded in 2003. It has raised $65.0M in total across 2 rounds, most recently a $61.5M Venture Round in Jan 2015. Investors include Royalty Pharma and BDC Venture Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Debt FinancingDebt Financing2024 (est.)
$250.0M

Sign up to see all 4 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zymeworks Inc. on Indexed.vc
<a href="https://indexed.vc/companies/zymeworks-inc"><img src="https://indexed.vc/api/badge/company/zymeworks-inc" alt="Zymeworks Inc. on Indexed.vc" width="260" height="76" /></a>